Samsara BioCapital as of June 30, 2022
Portfolio Holdings for Samsara BioCapital
Samsara BioCapital holds 56 positions in its portfolio as reported in the June 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Chinook Therapeutics | 24.1 | $90M | 5.2M | 17.49 | |
| Nkarta (NKTX) | 9.4 | $35M | 2.9M | 12.32 | |
| Scholar Rock Hldg Corp (SRRK) | 6.7 | $25M | 4.6M | 5.49 | |
| Graphite Bio | 6.2 | $23M | 8.5M | 2.75 | |
| Arcellx Common Stock (ACLX) | 5.1 | $19M | 1.1M | 18.08 | |
| Forma Therapeutics Hldgs SHS | 2.9 | $11M | 1.6M | 6.89 | |
| Lyra Therapeutics (LYRA) | 2.7 | $10M | 1.8M | 5.65 | |
| Aclaris Therapeutics (ACRS) | 2.6 | $9.7M | 696k | 13.96 | |
| Iveric Bio | 2.6 | $9.7M | 1.0M | 9.62 | |
| Intercept Pharmaceuticals In | 2.4 | $8.8M | 641k | 13.81 | |
| Sutro Biopharma (STRO) | 2.3 | $8.7M | 1.7M | 5.21 | |
| Rain Therapeutics | 2.3 | $8.7M | 1.6M | 5.56 | |
| Hillevax (HLVX) | 2.2 | $8.3M | 763k | 10.93 | |
| Instil Bio | 2.2 | $8.3M | 1.8M | 4.62 | |
| Centessa Pharmaceuticals Sponsored Ads (CNTA) | 2.2 | $8.2M | 1.7M | 4.87 | |
| Pepgen (PEPG) | 1.7 | $6.5M | 651k | 9.93 | |
| Immunocore Hldgs Ads (IMCR) | 1.6 | $6.0M | 161k | 37.31 | |
| Zymeworks | 1.4 | $5.1M | 971k | 5.30 | |
| Jiya Acquisition Corp Com Cl A | 1.3 | $5.0M | 507k | 9.88 | |
| Io Biotech (IOBT) | 1.3 | $4.7M | 1.0M | 4.67 | |
| Verona Pharma Sponsored Ads (VRNA) | 1.2 | $4.7M | 1.1M | 4.19 | |
| Janux Therapeutics (JANX) | 1.2 | $4.4M | 360k | 12.21 | |
| Dice Therapeutics | 1.0 | $3.9M | 254k | 15.52 | |
| Eyepoint Pharmaceuticals Com New (EYPT) | 1.0 | $3.8M | 480k | 7.87 | |
| Day One Biopharmaceuticals I (DAWN) | 0.9 | $3.5M | 196k | 17.90 | |
| Decibel Therapeutics | 0.9 | $3.4M | 802k | 4.21 | |
| Bcls Acquisition Corp Com Cl A | 0.8 | $3.0M | 300k | 9.90 | |
| Tango Therapeutics (TNGX) | 0.8 | $2.9M | 630k | 4.53 | |
| Igm Biosciences (IGMS) | 0.7 | $2.8M | 155k | 18.03 | |
| Viracta Therapeutics (VIRX) | 0.7 | $2.7M | 690k | 3.88 | |
| Novavax Com New (NVAX) | 0.6 | $2.3M | 45k | 51.45 | |
| Recursion Pharmaceuticals In Cl A (RXRX) | 0.6 | $2.2M | 268k | 8.14 | |
| Bolt Biotherapeutics (BOLT) | 0.6 | $2.1M | 1.0M | 2.04 | |
| Amryt Pharma Sponsored Ads | 0.6 | $2.1M | 305k | 6.99 | |
| Alx Oncology Hldgs (ALXO) | 0.6 | $2.1M | 263k | 8.09 | |
| Albireo Pharma | 0.5 | $2.0M | 100k | 19.86 | |
| Syros Pharmaceuticals | 0.5 | $1.8M | 1.9M | 0.96 | |
| Science 37 Holdings | 0.5 | $1.8M | 900k | 2.01 | |
| Avadel Pharmaceuticals Sponsored Adr | 0.4 | $1.6M | 659k | 2.44 | |
| Rhythm Pharmaceuticals (RYTM) | 0.4 | $1.4M | 345k | 4.15 | |
| Equillium (EQ) | 0.3 | $1.3M | 616k | 2.04 | |
| Vtv Therapeutics Cl A | 0.3 | $1.2M | 1.6M | 0.75 | |
| Elevation Oncology (ELEV) | 0.3 | $1.2M | 831k | 1.40 | |
| Surrozen | 0.2 | $900k | 300k | 3.00 | |
| Terns Pharmaceuticals (TERN) | 0.2 | $717k | 289k | 2.48 | |
| Atreca Cl A Com (BCEL) | 0.2 | $710k | 397k | 1.79 | |
| Springworks Therapeutics (SWTX) | 0.1 | $547k | 22k | 24.64 | |
| Allakos (ALLK) | 0.1 | $539k | 172k | 3.13 | |
| Aeglea Biotherapeutics | 0.1 | $446k | 884k | 0.50 | |
| Allovir (ALVR) | 0.1 | $321k | 82k | 3.90 | |
| Kronos Bio (KRON) | 0.1 | $284k | 78k | 3.63 | |
| Kala Pharmaceuticals | 0.0 | $180k | 601k | 0.30 | |
| Ngm Biopharmaceuticals | 0.0 | $175k | 14k | 12.80 | |
| Astria Therapeutics (ATXS) | 0.0 | $75k | 25k | 3.00 | |
| Nuvation Bio *w Exp 07/07/202 (NUVB.WS) | 0.0 | $37k | 133k | 0.28 | |
| Surrozen *w Exp 08/01/203 (SRZNW) | 0.0 | $19k | 100k | 0.19 |
